Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.73 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | PGR | P06401 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.50 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.50 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14407307 | 0.91 | LMNA (0.62) | LMNAMAPTTDP1PGRMAPK1 | |
| SCHEMBL14407313 | 0.91 | LMNA (0.62) | LMNAMAPTTDP1PGRMAPK1 | |
| SCHEMBL14407311 | 0.87 | LMNA (0.58) | LMNAMAPTTDP1PGRMAPK1 | |
| SCHEMBL13598262 | 0.87 | LMNA (0.58) | LMNAMAPTTDP1PGRMAPK1 | |
| SCHEMBL16999349 | 0.87 | LMNA (0.62) | LMNAMAPTTDP1PGRMAPK1 | |
| SCHEMBL4318927 | 0.86 | LMNA (0.61) | LMNAMAPTTDP1PGRMAPK1 | |
| Coenzyme Q2 SCHEMBL623496 | 0.86 | LMNA (0.97) | LMNAMAPTPGRMAPK1PDE3A | |
| Coenzyme Q2 SCHEMBL1506676 | 0.86 | LMNA (0.97) | LMNAMAPTPGRMAPK1PDE3A | |
| SCHEMBL16393869 | 0.85 | LMNA (1.00) | LMNAMAPTPGRMAPK1PDE3A | |
| Ubidecarenone SCHEMBL11901691 | 0.85 | LMNA (1.00) | LMNAMAPTPGRMAPK1PDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 662 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3346842-B1 | STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME | NOVONESIS PLANT BIOSOLUTIONS AS (DK) | 2026-03-25 | — | — | EP | claimed |
| EP-4033908-B1 | GLYCYRRHIZA AND THE PREVENTION OF LC-PUFA OXIDATION | NESTLE SA (CH) | 2026-02-25 | — | — | EP | claimed |
| EP-4504167-B1 | ORAL COMPOSITION CONTAINING DIMETHYLGLYCINE FOR IMPROVING THE CONDITION OF THE HAIR AND SCALP | DR KURT WOLFF GMBH & CO KG (DE) | 2026-02-18 | — | — | EP | claimed |
| EP-4658227-A1 | COSMETIC PREPARATION FOR PROTECTION FROM SKIN AGING | Beiersdorf AG (DE) | 2025-12-10 | — | — | EP | claimed |
| EP-3513188-B1 | RNA BIOMARKERS FOR HEREDITARY ANGIOEDEMA | TAKEDA PHARMACEUTICALS CO (JP) | 2025-12-03 | — | — | EP | claimed |
| EP-4643855-A2 | COMPOSITION FOR TREATING HAIR AND SKIN | Dr. Kurt Wolff GmbH & Co. KG (DE) | 2025-11-05 | — | — | EP | claimed |
| WO-2025224119-A1 | METHOD OF ENRICHING A CELL POPULATION CONTAINING INTACT AND DAMAGED CELLS IN A LIQUID MEDIUM | TrophoSYS GmbH (DE) | 2025-10-30 | — | — | WO | claimed |
| EP-3908297-B1 | FIBROBLAST REGENERATIVE CELLS | SPINALCYTE LLC (US) | 2025-10-22 | — | — | EP | claimed |
| EP-3373908-B1 | PROBIOTIC DELIVERY SYSTEMS | PROBIOTECH LLC (US) | 2025-10-22 | — | — | EP | claimed |
| EP-4619459-A1 | MODIFIED PU FOAM | Wenatex Forschung - Entwicklung - Produktion GmbH (AT) | 2025-09-24 | — | — | EP | claimed |
| EP-3474953-B1 | SUBSTANCE MIXTURE CONTAINING GLYCOSAMINOGLYCAN, METHOD FOR PRODUCING SAME AND USE OF SAME | FACH DR CHRISTIAN (DE) | 2022-11-16 | — | — | EP | claimed |
| EP-3337456-B1 | LIPOSOMES WITH GINSENOSIDE AS MEMBRANE MATERIAL AND PREPARATIONS AND USE THEREOF | SHANGHAI GINPOSOME PHARMATECH CO LTD (CN) | 2022-10-26 | — | — | EP | claimed |
| WO-2022192633-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING UBIQUINONE-5 AND METHOD OF USE THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2022-09-15 | — | — | WO | claimed |
| EP-3389620-B1 | STEM CELL STIMULATING COMPOSITIONS AND METHODS OF TREATING MELASMA | MEDICELL TECH LLC (US) | 2022-09-14 | — | — | EP | claimed |
| EP-4051222-A1 | COMPOSITION CONTAINING PREBIOTIC BACTERIA AND LICOCHALCONE A | Beiersdorf AG (DE) | 2022-09-07 | — | — | EP | claimed |
| EP-4051230-A1 | COMPOSITION CONTAINING PREBIOTIC BACTERIA AND PROTECTOR STRAINS | Beiersdorf AG (DE) | 2022-09-07 | — | — | EP | claimed |
| EP-3236937-B1 | CONTROLLED-RELEASE FORMULATIONS | CAMURUS AB (SE) | 2022-05-04 | — | — | EP | claimed |
| EP-3398622-B1 | IRON-BASED ALLOY ABSORBABLE AND IMPLANTABLE MEDICAL DEVICE FOR INTERNAL FIXATION | BIOTYX MEDICAL SHENZHEN CO LTD (CN) | 2022-03-16 | — | — | EP | claimed |
| EP-2283151-B1 | DIHYDROOROTATE DEHYDROGENASE AS ANTIFUNGAL DRUG TARGET | F2G LTD (GB) | 2017-03-08 | — | — | EP | claimed |
| US-9034887-B2 | Dihydroorotate dehydrogenase as antifungal drug target and quinazolinone-based inhibitors thereof | F2G LIMITED (GB) | 2015-05-19 | — | — | US | claimed |